Solventum Corp at Piper Sandler Healthcare Conference Transcript
All right. Good morning, everyone. Thanks for joining us today. I'm Jason Bednar. I cover Medtech here at Piper. Next fireside chat is with Solventum. Very happy to have with us today Solventum's Chief Strategy and Corporate Development Officer, Rachel Ellingson; also Amy Wakeham from Solventum Investor Relations.
So thanks for joining us both. I really appreciate it. And we're going to just dive right into Q&A, if that's all right.
Sounds great.
Questions & Answers
So we had some recent news to talk about. I'm really glad you're here, Rachel. So we're looking forward to talking about the deal you announced here recently. You're the perfect person to talk about it.
But before we get to that, I think it would just be helpful for everyone in the room. They may not be as familiar with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
